Landscapes / Companies

Sarepta Therapeutics, Inc. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
SRP-1003, Phase 1/2 trial completes
Drugs
5
in active trials · 13 in all
Trials
5 active
20 since 2021

Drugs5

DrugHow it worksPartnerStageNext dateDetails
Gene therapy substances
Approved 31 Aug 2027Phase 4 trial completes
—
Phase 3 —
—
Phase 1/2 31 Dec 2026Phase 1/2 trial completes
—
Phase 1/2 31 Dec 2028Phase 1/2 trial completes
—
Phase 1 30 Nov 2027Phase 1 trial completes

About

No active trial
8 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 20 Nov 2026 Industry-sponsored drug trials since 2021

Follow Sarepta Therapeutics, Inc.

Following is part of Solo: you see every change to Sarepta Therapeutics, Inc. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in